O-089 ERCC1 mRNA-based randomized phase III trial of...

Lung Cancer 2005 / 7 Vol. 49

O-089 ERCC1 mRNA-based randomized phase III trial of docetaxel (doc) doublets with cisplatin (cis) or gemcitabine (gem) in stage IV non-small-cell lung cancer (NSCLC) patients (p)

Cobo, M., Isla, D., Sánchez, J., Massuti, B., Montes, A., Paz-Ares, L., Múñoz, M., Viñolas, N., Lopez-Vivanco, G., Felip, E.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80223-5
Date:
July, 2005
File:
PDF, 131 KB
english, 2005
Conversion to is in progress
Conversion to is failed